Sulfation of fulvestrant by human liver cytosols and recombinant SULT1A1 and SULT1E1

Fulvestrant (Faslodex™) is a pure antiestrogen that is approved to treat hormone receptor-positive metastatic breast cancer in postmenopausal women. Previous studies have demonstrated that fulvestrant metabolism in humans involves cytochromes P450 and UDP-glucuronosyltransferases (UGTs). To date, fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Edavana, Vineetha Koroth, Yu, Xinfeng, Dhakal, Ishwori B, Williams, Suzanne, Ning, Baitang, Cook, Ian T, Caldwell, David, Falany, Charles N, Kadlubar, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400326/
https://www.ncbi.nlm.nih.gov/pubmed/22822301
http://dx.doi.org/10.2147/PGPM.S25418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400326/
https://www.ncbi.nlm.nih.gov/pubmed/22822301
http://dx.doi.org/10.2147/PGPM.S25418

Ejemplares similares